1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Glucose Biosensor Market Size & Forecast By End-use , By Region And Trend Analysis From 2015 To 2022

Industry Insights

The global glucose biosensor market was estimated at USD 15.3 billion in 2015. Increasing incidence of diabetes across the globe is expected to be a key factor driving market growth. Diabetes is one of the most commonly occurring diseases worldwide. It is expected to be one of the leading causes of mortality all over the world.

Rising prevalence of diabetes globally is a major factor attributing towards the growth of this market. Blood glucose monitoring is being used as a necessary tool in diabetes management. As maintenance of normal blood glucose levels is important for the patients suffering from diabetes, a series of apt glucose biosensors have been developed to meet the needs of the patients suffering from this highly prevalent disorder. Furthermore, the growing demand for self-monitoring devices has augmented the use of biosensors especially in portable forms. Glucose sensors are now available as small and minimally invasive devices that measure glucose levels even in outpatient settings.

Monitoring of blood glucose level at regular intervals is one of the key factors required for disease management. Owing to this fact, several technical improvements have been carried out in the development of sensors. However, development of reliable and accurate glucose biosensors is still a challenge for market participants.

The introduction of technological advancements is expected to play an integral role in boosting usage rates. This is evident from the development of minimal and non-invasive glucose biosensors in the market. Several companies, including small and major, players are involved in extensive R&D initiatives to develop less painful, cost-effective, more accurate, and reliable products.

For instance, NovioSense, a glucose sensor manufacturing company in the Netherlands, has developed a non-invasive sensor to monitor glucose levels in tears. However, the presence of alternative methods, such as laboratories tests, for monitoring of glucose levels in blood are expected to hinder market growth over the forecast period.

End-use Insights

On the basis of end-user, the market is fragmented into hospitals, homecare diagnostics, and others. The others section includes research institutes, clinical, and diagnostic laboratories. Homecare diagnostics market in terms of value was estimated to account for the largest share of over 46.0% in 2015.

The homecare diagnostic segment involves the use of point of care devices including hand-held glucose meters. These devices are portable, easy-to-use, cost-effective, and yield quick results. Additionally, the application of these devices reduces frequent visits to the hospitals.

Regional Insights

Key regions considered while analyzing this market include North America, Europe, Asia Pacific, Latin America, and MEA. In terms of revenue, North America is expected to lead the market in terms of revenue and is also anticipated to grow rapidly during the forecast period. Growing burden of diabetes is one of the key factors attributing to accelerated regional market growth. Diabetes is expected to be one of the leading causes of illness and death in the U.S. region.

Asia Pacific is projected to witness rapid growth over the forecast period. With the increasing prevalence of diabetes in China and India, the Asia Pacific market is anticipated to experience a rapid boost in demand estimates at a CAGR of 13.0% from 2015 to 2022. As of 2013, China and India were estimated to account for 65.3% people with diabetes on a global level.

Competitive Market Share Insights

Some key players operating in this market include Roche, Bayer, LifeScan Inc., and Abbott. In 2014, collectively, these companies held a market share of more than 70.0%. The companies are actively involved in new product development, technological advancements, partnerships, joint ventures, and collaborations, in an attempt to ensure sustainability and register growth.

For instance, in January 2015, LifeScan Inc. introduced new blood glucose monitoring system, OneTouch Verio. The new product is easy-to-use and offers better understanding of the test results.

Table Of Contents

Glucose Biosensor Market Size and Forecast By End-use , By Region And Trend Analysis From 2015 To 2022
Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope and assumption
1.3. List of data sources
Chapter 2. Executive Summary
2.1. Glucose biosensors Market - Industry Summary and Key Buying Criteria, 2012 - 2020
Chapter 3. Glucose biosensors Industry Outlook
3.1. Market segmentation
3.2. Market size and growth prospects, 2012-2020
3.3. Glucose biosensors: Market dynamics
3.3.1. Market driver analysis
3.3.1.1. Rising prevalence of diabetes
3.3.1.2. Presence of a strong range of products in pipeline
3.3.1.3. Growing prevalence of lifestyle induced disorders such as obesity
3.3.2. Market restraint analysis
3.3.2.1. Presence of alternative methods
3.4. Glucose biosensors market: Industry trend analysis
3.5. Glucose biosensors Market - PESTEL Analysis
3.6. Glucose biosensors Industry analysis - Porter's Five Forces Model
3.7. Glucose biosensors: Company Market Share Analysis , 2014
3.8. Key opportunities prioritized
Chapter 4. Glucose Biosensors End-User Application Outlook
4.1. Glucose Biosensors Revenue Share Analysis, by End-User Application, 2014 and 2022
4.2. Hospital
4.2.1. Hospital market revenue, by region, 2012 to 2022
4.3. Homecare Diagnostics
4.3.1. Homecare diagnostics market revenue, by region, 2012 to 2022
4.4. Others
4.4.1. Others market revenue, by region, 2012 to 2022
Chapter 5. Glucose Biosensors Regional Outlook
5.1. Glucose Biosensors Market Share Analysis, by Region, 2014 and 2022
5.2. North America
5.2.1. U.S.
5.2.1.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.2.2. Canada
5.2.2.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.3. Europe
5.3.1. Germany
5.3.1.1. glucose biosensors market, by end-user application, 2012 - 2022
5.3.2. U.K.
5.3.2.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.3.3. Rest of Europe
5.3.3.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.4. Asia Pacific
5.4.1. China
5.4.1.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.4.2. India
5.4.2.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.4.3. Rest of Asia Pacific
5.4.3.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.5. MEA
5.5.1. South Africa
5.5.1.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.5.2. Saudi Arabia
5.5.2.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.5.3. Rest of MEA
5.5.3.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.6.2. Mexico
5.6.2.1. Glucose biosensors market, by end-user application, 2012 - 2022
5.6.3. Rest of Latin America
5.6.3.1. Glucose biosensors market, by end-user application, 2012 - 2022
Chapter 6. Competitive Landscape
6.1. Roche Diagnostics
6.1.1. Company Overview
6.1.2. Financial Performance
6.1.3. Product Benchmarking
6.1.4. Strategic Initiatives
6.2. LifeScan Inc.
6.2.1. Company Overview
6.2.2. Financial Performance
6.2.3. Product Benchmarking
6.2.4. Strategic Initiatives
6.3. Abbott Laboratories
6.3.1. Company Overview
6.3.2. Financial Performance
6.3.3. Product Benchmarking
6.3.4. Strategic Initiatives
6.4. Bayer
6.4.1. Company Overview
6.4.2. Financial Performance
6.4.3. Product Benchmarking
6.4.4. Strategic Initiatives
6.5. Medtronic Inc.
6.5.1. Company Overview
6.5.2. Financial Performance
6.5.3. Product Benchmarking
6.5.4. Strategic Initiatives
6.6. Pinnacle Medical Solutions Inc.
6.6.1. Company Overview
6.6.2. Financial Performance
6.6.3. Product Benchmarking
6.6.4. Strategic Initiatives
6.7. AgaMatrix Inc.
6.7.1. Company Overview
6.7.2. Financial Performance
6.7.3. Product Benchmarking
6.7.4. Strategic Initiatives
6.8. Sanofi S.A.
6.8.1. Company Overview
6.8.2. Financial Performance
6.8.3. Product Benchmarking
6.8.4. Strategic Initiatives
6.9. BioSense Medical Devices, LLC
6.9.1. Company Overview
6.9.2. Financial Performance
6.9.3. Product Benchmarking
6.9.4. Strategic Initiatives
6.10. Nova Biomedical
6.10.1. Company Overview
6.10.2. Financial Performance
6.10.3. Product Benchmarking
6.10.4. Strategic Initiatives


List of Tables

1. Glucose Biosensors - Industry Snapshot and Key Buying Criteria, 2012 - 2022
2. Global glucose biosensors market revenue, by end-user application, 2012 - 2022
3. Global glucose biosensors market, by region, 2012 - 2022
4. Glucose Biosensors - Key Market Driver Analysis
5. Glucose Biosensors - Key Market Restraint Analysis
6. North America glucose biosensors market revenue, by end-user application, 2012 - 2022
7. U.S. glucose biosensors market revenue, by end-user application, 2012 - 2022
8. Canada glucose biosensors market revenue, by end-user application, 2012 - 2022
9. Europe glucose biosensors market revenue, by end-user application, 2012 - 2022
10. Germany glucose biosensors market revenue, by end-user application, 2012 - 2022
11. U.K. glucose biosensors market revenue, by end-user application, 2012 - 2022
12. Rest of Europe glucose biosensors market revenue, by end-user application, 2012 - 2022
13. Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022
14. China glucose biosensors market revenue, by end-user application, 2012 - 2022
15. India glucose biosensors market revenue, by end-user application, 2012 - 2022
16. Rest of Asia Pacific glucose biosensors market revenue, by end-user application, 2012 - 2022
17. Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022
18. Brazil glucose biosensors market revenue, by end-user application, 2012 - 2022
19. Mexico glucose biosensors market revenue, by end-user application, 2012 - 2022
20. Rest of Latin America glucose biosensors market revenue, by end-user application, 2012 - 2022
21. MEA glucose biosensors market revenue, by end-user application, 2012 - 2022
22. South Africa glucose biosensors market revenue, by end-user application, 2012 - 2022
23. Saudi Arabia glucose biosensors market revenue, by end-user application, 2012 - 2022
24. Rest of MEA glucose biosensors market revenue, by end-user application, 2012 - 2022


List of Figures

1. Global glucose biosensors: Market segmentation
2. Global glucose biosensors, 2012 - 2022
3. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years
4. Global glucose biosensors market: Industry trend analysis
5. Global glucose biosensors market: PESTEL analysis
6. Global glucose biosensors market: Porter's analysis
7. Glucose biosensors company market share, 2014
8. Key Opportunities Prioritized
9. Glucose biosensors market revenue share by end-user application, 2014 and 2022
10. Hospitals glucose biosensors market revenue, 2012 to 2022
11. Homecare diagnostics glucose biosensors market revenue, 2012 to 2022
12. Others market revenue, 2012 to 2022
13. Glucose biosensors market share, by region, 2014 and 2022

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.